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Mucosal-associated invariant T (MAIT) cells represent a class of antimicrobial innate-like 
T cells that have been characterized in human blood, liver, lungs, and intestine. Here, 
we investigated, for the first time, the presence of MAIT cells in the stomach of children, 
adults, and the elderly undergoing routine endoscopy and assessed their reactivity to 
Helicobacter pylori (H. pylori – Hp), a major gastric pathogen. We observed that MAIT 
cells are present in the lamina propria compartment of the stomach and display a similar 
memory phenotype to blood MAIT cells. We then demonstrated that gastric and blood 
MAIT cells are able to recognize H. pylori. We found that CD8+ and CD4−CD8− (double 
negative) MAIT cell subsets respond to H. pylori-infected macrophages stimulation in a 
MR-1 restrictive manner by producing cytokines (IFN-γ, TNF-α, IL-17A) and exhibiting 
cytotoxic activity. Interestingly, we observed that blood MAIT cell frequency in Hp+ve 
individuals was significantly lower than in Hp−ve individuals. However, gastric MAIT cell 
frequency was not significantly different between Hp+ve and Hp−ve individuals, demon-
strating a dichotomy between blood and gastric tissues. Further, we observed that the 
majority of gastric MAIT cells (>80%) expressed tissue-resident markers (CD69+ CD103+), 
which were only marginally present on PBMC MAIT cells (<3%), suggesting that gastric 
MAIT cells are readily available to respond quickly to pathogens. These results contribute 
important new information to the understanding of MAIT cells function on peripheral and 
mucosal tissues and its possible implications in the host response to H. pylori.
Keywords: gastric MaiT, stomach, cytotoxic, H. pylori, age-related
introduction
Innate T cells are distinct from conventional T cells in that they have a limited repertoire diversity and 
that their responses display innate-like properties (1). Three subsets of innate T cells have been impli-
cated in detection and response to pathogens, i.e., natural killer T cells (NKT), gamma-delta (γδ) T 
cells, and mucosal-associated invariant T (MAIT) cells (2–4). These cell subsets are phylogenetically 
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conserved, express defined chemokine receptors, and are local-
ized in peripheral tissues, particularly in mucosal tissues (5, 6). 
While NKT and γδ T cells have been studied extensively, much 
less information is available regarding MAIT cells characteriza-
tion and function. In humans, intestinal innate T cells have been 
described in two distinct compartments: the lamina propria (LP) 
and the epithelial layer (5, 7). Although NKT and γδ T cells have 
been characterized in the gastric mucosa (8, 9), the presence of 
MAIT cells has not been reported. We have previously shown that 
gastric LP mononuclear cells (LPMCs) obtained from healthy 
volunteers contained more CD8+ T cells than CD4+ T cells, 
making the presence of CD8+ MAIT cells in the gastric milieu a 
distinct possibility (10).
Mucosal-associated invariant T cells are unique MHC-Ib-
restricted T lymphocytes that express a semi-invariant T-cell 
receptor (Vα7.2 in humans) together with high levels of the NK 
receptor CD161. While the majority of MAIT cells display a CD8+ 
(αα or αβ) phenotype, double-negative (DN; CD4−CD8−) and 
CD4+ MAIT cells have also been reported (11). MAIT cells have 
been described as effector memory cells (5, 12). Recent studies 
have shown that human MAIT cells have the capacity to react rap-
idly to pathogens by producing IFN-γ and TNF-α in response to 
antigen-presenting cells (APCs) infected with several organisms, 
including Mycobacterium tuberculosis, Salmonella enterica sero-
var Typhimurium, and Salmonella typhi (4, 13, 14). MAIT cells 
do not, however, react to all pathogens (4). For example, MAIT 
cells were unable to respond to either Listeria monocytogenes or 
Streptococcus (4).
Helicobacter pylori (H. pylori) is a Gram-negative, microaero-
philic bacterium that colonizes the human stomach, establishing 
a chronic infection in about two-thirds of the World population 
(15). H. pylori infection increases the risk for several clinical dis-
orders such as gastritis, peptic ulcer, and gastric adenocarcinoma 
(15). The present investigations were undertaken to determine 
whether MAIT cells, if present in the gastric mucosa, might play a 
role in H. pylori infection. The presence of the riboflavin synthesis 
pathway in H. pylori supports the notion that these bacteria could 
produce the ligands required for stimulation of MAIT cells.
In this study, we showed for the first time that MAIT cells 
are present in the human gastric mucosa and display a memory 
phenotype similar to that observed in blood. Furthermore, we 
demonstrated that CD8+ and DN MAIT subsets are activated, in 
an MR-1-restricted manner, by H. pylori-infected macrophages 
(Mϕ) as evidenced by a robust production of cytokines and 
cytotoxic ability to lyse H. pylori-infected macrophages. We also 
observed significantly lower frequencies of CD8+ MAIT cells in 
blood, but not in the gastric mucosa, of Hp+ve volunteers when 
compared with Hp−ve volunteers. This is the first demonstration of 
MAIT cell subsets in the human stomach and their response to H. 
pylori infection, significantly extending our understanding of the 
role of MAIT cells in peripheral and mucosal tissues.
Materials and Methods
Volunteers
Volunteers were recruited from the Baltimore–Washington met-
ropolitan area and University of Maryland, Baltimore, campus. 
Written informed consent was obtained from volunteers, and 
all procedures were approved by the University of Maryland, 
Baltimore Institutional Review Board. Blood and gastric biopsies 
were collected from 46 clinically indicated esophagogastroduo-
denoscopy (EGD) volunteers [children: 7–17  years (n  =  12); 
adult: 18–64 years (n = 24); elderly: 65–85 years (n = 10)]. The 
indications for EGD included abdominal pain, heartburn, GERD, 
dysphagia, and acute gastritis. Diagnostic pathology reports 
showed that the stomach’s antral mucosa for the volunteers was 
either normal or exhibited mild inflammation. No concurrent GI 
diseases/disorders or other illnesses that may affect the GI tract 
were present. The presence of H. pylori infection was evaluated 
by culture and rapid urease test (CLO test) (16). All volunteers 
were H. pylori negative except where indicated in the narrative. 
In addition, PBMC collected from 11 healthy adult volunteers 
were also used in this study. PBMCs were isolated immediately 
after blood draws by density gradient centrifugation and cryo-
preserved in liquid nitrogen following standard techniques (17).
isolation of lPMcs from gastric Biopsies
Gastric LPMCs were isolated as described previously (10). 
Briefly, after collection of biopsies from clinically indicated 
EGD volunteers, tissues were treated with HBSS (without CaCl2, 
MgCl2, MgSO4) (Gibco, Carlsbad, CA, USA) and EDTA (1 mM; 
Ambion, Grand Island, NY, USA) to remove intraepithelial cells. 
LPMCs were then isolated following enzymatic digestion of the 
biopsies with collagenase D (100  μg/ml; Roche, Indianapolis, 
IN, USA) and DNase I (10 μg/ml; Affymetrix, Cleveland, OH, 
USA) and homogenization using the Bullet Blender homogenizer 
(Next Advance Inc., Averill, NY, USA). Cells were then washed 
and resuspended in complete medium [RPMI 1640 (Gibco 
Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat-
inactivated fetal bovine serum (BioWhittaker, Walkersville, MD, 
USA), 2 mM l-glutamine (HyClone, Logan, UT, USA), 2.5 mM 
sodium pyruvate (Gibco), and 10 mM HEPES (Gibco), 100 U/ml 
penicillin (Sigma-Aldrich, St. Louis, MO, USA), 100 μg/ml strep-
tomycin (Sigma-Aldrich), and 50 μg/ml gentamicin (Gibco)] and 
counted using Kova Glastic Slides (Hycor Biomedical, CA, USA). 
Cells were either stained immediately for immunophenotyping 
by flow cytometry or overnight stimulated with mitogens before 
staining (see below).
H. pylori growth conditions
H. pylori strain 26695 (ATCC, Manassas, VA, USA) was grown 
on Columbia blood agar (Difco) containing 7% defibrinated 
horse blood (Hemostat Laboratories, Dixon, CA, USA), 
amphotericin B (2.5 μg/ml), and the selective antibiotics tri-
methoprim (20 μg/ml), vancomycin (6 μg/ml), and cefsulodin 
(16 μg/ml) (Sigma-Aldrich). Cultures were grown in a desig-
nated CO2 incubator with a humidity tray at 37°C and 10% CO2 
for 72–96 h. In preparation for coculture assays with THP-1 
macrophages, bacteria were transferred to 10 ml Brucella broth 
(Difco) containing 10% FBS plus antibiotics in 25-cm2 tissue 
culture flasks overnight. Bacterial density was determined by 
obtaining readings at an optical density of 450 nm (OD, 450) 
and comparing them to a standardized growth curve, a value 
of 0.071 corresponding to 1 × 107 bacteria/ml.
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Preparation of H. pylori lysate antigen
H. pylori strain 26695 was grown on Columbia agar (Difco) sup-
plemented with 7% horse blood under microaerobic conditions 
(5% O2, 10% CO2) at 37°C. After 96 h, bacteria were harvested and 
cultured in tissue culture flasks containing Brucella broth (Difco) 
supplemented with 10% fetal bovine serum. Cultures were grown 
at 37°C with 5% CO2. Bacterial cultures were recovered by cen-
trifugation at 4,000 × g for 20 min and then suspended in 2 ml 
phosphate-buffered saline (PBS). Bacteria were lysed by 4 × 60 s 
bursts of power using a probe sonicator (Sonics and Materials 
Inc., Danbury, CT, USA). Whole bacteria were removed by cen-
trifugation at 5,000 × g for 20 min and passing the supernatant 
through a 0.22-μm pore filter (18).
culture, Differentiation, and infection of ThP-1
The human monocyte cell line THP-1 (ATCC catalog # TIB-202) 
was cultured and differentiated as described previously (19). 
Briefly, THP-1 cells were cultured in complete RPMI described 
above at 5% CO2 at 37°C. THP-1 cells were then differentiated 
into macrophages (Mϕ) by incubating with phorbol 12-myristate 
13-acetate (PMA) (50  ng/ml; Sigma-Aldrich) for 48  h at 37°C 
in 5% CO2. The level of cell differentiation was evaluated by 
surface staining of the cells with antibodies against the classical 
macrophage marker CD68 (Y1/82A, Biolegend, San Diego, CA, 
USA). Cells were then washed and incubated overnight in com-
plete RPMI before infection with H. pylori. THP-1-differentiated 
Mϕ were washed in antibiotics-free medium and counted using 
the viability dye Trypan blue to determine the number of viable 
THP-1 macrophages. A total of 1 × 106 THP-1 were incubated 
in complete RPMI without antibiotics for 4 h at 37°C in 5% CO2 
in the absence or presence of H. pylori at 5, 10, 20, 50, and 100 
multiplicity of infection (MOI). The infection was stopped by 
the addition of fresh complete RPMI 1640 medium containing 
gentamicin (100 μg/ml; Sigma-Aldrich). Cells were then labeled 
with CD45, a marker present in all hematopoietic cells, to exclude 
infected Mϕ from flow cytometry analysis. To allow the cells to 
recover from the infection, infected Mϕ were rested for overnight 
at 37°C before coculturing with PBMC. Negative controls (i.e., 
non-infected Mϕ) were treated identically except that they were 
not infected with H. pylori. The levels of infection were deter-
mined both by flow cytometry using a goat-anti-Helicobacter 
pylori antiserum (02-03-94, KPL, Gaithersburg, MD, USA) and 
by bacteria entry assays as described below.
Bacteria entry assay
Bacteria entry experiments were performed as previously 
described (20). Briefly, after gentamicin treatment, 2 × 105 Mϕ 
were lysed using 0.1% saponin in PBS. Lysates were plated in 
serial dilution on solid GC agar plates supplemented with 10% 
horse serum and vancomycin for 48 h under microaerobic condi-
tions, 10% CO2 at 37°C to detect intracellular bacteria.
isolation and culture of Primary Macrophages
Primary macrophages cells were isolated from PBMC by adhe-
sion to tissue culture plastic plates as described previously (21). 
Macrophages were >90% pure as determined by staining with 
CD14 and CD68. Isolated primary macrophages were harvested 
using a rubber policeman and were then infected with H. pylori 
at MOI of 20. For blocking experiments, H. pylori-infected 
macrophages were pre-treated with anti-MR-1 mAb (10 μg/ml, 
clone 26.5, Biolegend) or their matched isotype control mouse 
IgG2a (10 μg/ml, MOPC-173, Biolegend) before coculture with 
autologous effector cells.
stimulation of PBMc and gastric lPMc for  
Flow cytometry analyses
Ex vivo PBMCs were used as effector cells. Briefly, PBMCs 
were cocultured with live H. pylori (MOI of 50), H. pylori lysate 
(homogenate; 5 μg/ml), non-infected Mϕ, or H. pylori-infected 
Mϕ (MOI of 20). The effector:H. pylori-infected Mϕ ratios were 
50:1, 20:1, 10:1, and 5:1. PBMCs cultured with media only or in 
the presence of staphylococcal enterotoxin B (SEB) (10 μg/ml; 
Sigma) were used as negative and positive controls, respectively. 
Freshly isolated gastric LPMCs were cocultured with media alone, 
non-infected Mϕ, H. pylori-infected Mϕ (MOI of 20) (Effector:H. 
pylori infected-Mϕ ratio was 50:1), or anti-CD3/CD28 beads 
(positive control; Life technologies, Grand Island, NY, USA). 
In some experiments (see Results), at the time of stimulation, 
anti-human CD107a-FITC (5 μl; H4A3, BD, San Jose, CA, USA) 
was added. After 4 h, 0.5 μl of Golgi Stop (Monensin, BD, USA) 
and Golgi Plug (Brefeldin A, BD, USA) were added and cultures 
continued overnight at 37°C in 5% CO2.
surface and intracellular staining
Following stimulation, PBMCs and LPMCs were stained for 
flow cytometry analysis as previously described (10). Following 
stimulation in the presence of CD107a [LAMP-1, a molecule 
expressed on the cell membrane which is widely accepted to 
be associated with cytotoxic T-cell activity (22)), PBMCs and 
LPMCs were stained for live/dead discrimination (YEVID) 
(Invitrogen, Carlsbad, CA, USA). Blocking of Fc receptors was 
performed using human immunoglobulin (3  μg/ml; Sigma) 
and was followed by surface staining. Briefly, cells were stained 
with fluorescently labeled monoclonal antibodies (mAbs) 
directed to CD14-BV570 (M5E2, Biolegend, San Diego, CA, 
USA), CD19-BV570 (HIB19, Biolegend), CD3-BV650 (OKT3, 
Biolegend), CD4-PerCP-Cy5.5 (SK3, BD), CD8-biotin (RPA-T8, 
BD), CD45RA-BV605 (HI100, Biolegend), TCR Vα7.2-PE (3C10, 
Biolegend), CD103-Alexa-Fluor 488 (Ber-ACT8, Biolegend), 
CD161-APC (DX12, BD), and CD62L-Alexa Fluor 780 (DREG-
5, eBioscience, San Diego, CA, USA) at 4°C for 30 min. Staining 
with streptavidin-QDot800 (Invitrogen) was performed for 
panels that included biotin-conjugated mAbs for 30 min at 4°C. 
Cells were then fixed and permeabilized using IC fixation and 
permeabilization buffers (8222/8333, eBioscience) according 
to the manufacturer’s recommendations. This was followed by 
intracellular staining with mAbs directed to IL-17A-BV421 
(BL168, Biolegend), IFNγ-PE-Cy7 (B27, BD), TNFα-Alexa 700 
(MAb11, BD), and CD69-ECD (TP1.55.3, Beckman Coulter, 
Danvers, MA, USA) which was performed at 4°C overnight. 
After staining, cells were stored in 1% paraformaldehyde at 4°C 
until data collection. Data were collected using a customized 
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LSRII flow cytometer (BD) and then analyzed using the WinList 
version 7 (Verity Software House, Topsham, ME, USA) software 
package. Functional responses were considered specific for H. 
pylori-infected autologous macrophages if the differential in the 
number of positive and negative events between experimental 
(H. pylori-infected Mϕ) and negative control (uninfected Mϕ) 
cultures were significantly increased (P < 0.05) using z-tests.
cytotoxic T lymphocyte assays
In  vitro-expanded PBMC from volunteers were obtained and 
used for cytotoxic T lymphocyte (CTL) as previously described 
for S. typhi (17). Briefly, PBMCs were cocultured with stimulator 
cells at an effector to stimulator cell ratio of 7:1 in complete RPMI 
supplemented with 20 IU/ml of rhIL-2 for 7–8 days. Stimulator 
cells consisted of THP-1 Mϕ infected with H. pylori (MOI-20). 
After infection, THP-1 Mϕ were rested overnight and gamma-
irradiated (4,000  rads). For blocking experiments, stimulators 
were pre-treated for 1  h with anti-MR1 polyclonal antibodies 
[10 μg/ml, Santa Cruz Biotechnology (SC), San Diego, CA, USA], 
or anti-MR1 mAb (10 μg/ml, clone 26.5, kindly provided by Dr. 
Ted H. Hansen) or their matched controls (10 μg/ml), goat IgG 
(Gene Tex Inc, Irvine, CA, USA) and mouse IgG2a (MOPC-173, 
Biolegend), respectively, before coculture with effector cells. 
Cytotoxicity was determined by a 4-h 51Cr-release assay as previ-
ously described (17). Briefly, serial twofold dilutions of expanded 
effector cells (1.87 × 104 to 1.5 × 105 cells/well) were incubated 
with H. pylori-infected and non-infected Mϕ target cells (3 × 103 
cells/well) previously labeled with 200 μCi of 51CrO4Na2 (MP 
Biomedical, Solon, OH, USA). Cultures were centrifuged at 
50 × g for 5 min and incubated for 4 h at 37°C in the presence 
of 5% CO2. Supernatants were then collected and transferred to 
96-well plates containing scintillation liquid (OptiPhase; LKB 
Wallac, Gaithersburg, MD, USA). The amount of 51Cr released was 
measured with a Wallac Trilux β-counter (LKB Wallac). Cultures 
were tested in triplicate wells. The percentage of cytotoxicity 
was calculated as follows: (experimental release − spontaneous 
release)/(maximal release − spontaneous release) × 100, where 
spontaneous release is the counts per minute released by target 
cells in the absence of effector cells and maximal release is the 
counts per minute released in the presence of 5% Triton X-100 as 
previously described (17).
statistical analysis
Data were analyzed using the statistical software GraphPad 
Prism™ version 5.03 (Graphpad, San Diego, CA, USA). Kruskal–
Wallis ANOVA and Dunn’s post-test were used to determine 
significant differences between multiple groups and to compare 
selected group pairs. Statistical differences in median values 
between two groups were determined using Mann–Whitney 
tests. Correlations between MAIT cell frequencies and age were 
evaluated using Spearman’s tests.
results
MaiT cells are Present in the stomach
To evaluate whether MAIT cells are present in the human 
stomach, we isolated LPMCs from gastric biopsies obtained 
from various age groups and characterized them by flow 
cytometry. We then compared the phenotype and function of 
MAIT cells present in the stomach with those present in the 
blood. As expected, blood MAIT cells were detected in the 
three major T-cell subsets CD8+, CD4+, and CD4−CD8− (DN) 
(Figure 1A; Figure S1 in Supplementary Material). Although at 
different proportions, gastric MAIT cells were also composed 
of three different subsets: CD8+, CD4+, and DN MAIT cell 
subsets (Figure  1B; Figure S1 in Supplementary Material). 
Cumulative data showed that the percentages of gastric CD8+ 
and DN MAIT cell subsets were significantly lower than their 
counterpart MAIT subsets in blood (Figure 1C). In addition, 
the percentages of blood and gastric CD8+ and DN MAIT cell 
subsets were significantly higher than CD4+ MAIT subsets 
(Figure 1C).
Since MAIT cells have been shown to display a T-cell effector 
memory (TEM) phenotype (5, 12), we evaluated the phenotype 
of blood and gastric MAIT cell subsets by assessing CD45RA 
and CD62L expression in the two major MAIT cell subsets 
(CD8+ and DN). Blood MAIT cell subsets showed comparable 
levels of TEM (CD62L−CD45RA−) in CD8+ and DN MAIT subsets 
(Figure 1D). Similarly, phenotypic analysis of gastric MAIT cell 
subsets showed that CD8+ and DN MAIT subsets displayed 
similar levels of TEM phenotypes (~70–80%) (Figure 1E). We then 
compared blood and gastric MAIT cell subtypes displaying the 
TEM phenotype. We found that gastric LPMCs have significantly 
higher MAIT cells expressing a TEM phenotype than blood in both 
MAIT subsets (Figure 1F).
Because the presence of MAIT cells in the human gastric 
mucosa was not previously reported, we determined their fre-
quency in gastric biopsies obtained from children, adults, and the 
elderly and compared these frequencies to blood MAIT cells. The 
frequencies of both MAIT cell subsets (CD8+ and DN) in blood 
were found to be significantly higher in children than in adults 
and the elderly (Figure 2A). In contrast, in LPMC, although some 
trends were noted, MAIT cell subsets frequencies were not dif-
ferent among the three age groups (Figure 2B). Using Pearson’s 
regression analysis, we observed a significant inverse correlation 
(r = −0.35, P = 0.016) between the frequency of the CD8+ MAIT 
subset and age in PBMC but not in LPMC (r = −0.03, P = 0.847) 
(Figures  2C,D). Regression analysis of DN subsets showed 
similar results, i.e., significant inverse correlations between the 
frequencies of blood DN (r = −0.33, P = 0.022) MAIT subsets 
and age (Figure S2A in Supplementary Material). Similar to 
LPMC CD8+ MAIT, DN MAIT subset showed a trend to be cor-
related (r = 0.25, P = 0.10) with age (Figure S2B in Supplementary 
Material).
activation of Blood MaiT cells with live  
H. pylori or lysate
The observation that MAIT cells were present at the gastric 
mucosa led us to speculate that MAIT cells might play a role 
in H. pylori infection, a major gastric pathogen. To explore 
this possibility, we determined the ability of blood MAIT cells 
from individuals to be activated following exposure to H. pylori 
antigens or live H. pylori bacteria by assessing their cytokines/
cytotoxic (IFN-γ, TNF-α, and CD107a) responses. Blood MAIT 
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cells were characterized using the gating strategy described in 
Figure  1A and Figure S1 in Supplementary Material. While 
exposure to H. pylori antigens (lysate) did not stimulate blood 
CD8+ MAIT cells, exposure of these cells to live H. pylori bac-
teria (MOI of 50) resulted in increased expression of CD107a 
(5.3%) and low levels of TNF-α production (0.8%) (Figure S3A 
in Supplementary Material). As expected, the positive control, 
SEB, stimulated CD8+ MAIT cells to produce high levels of IFN-γ 
and TNF-α and up-regulate CD107a expression, demonstrating 
that these cells were functional (Figure S3A in Supplementary 
Material).
Blood cD8+ MaiT cells activation by  
H. pylori-infected Macrophages
Given the modest response of MAIT cells to live H. pylori 
stimulation, we explored whether stimulation of blood CD8+ 
MAIT cells with H. pylori-infected macrophages (Mϕ) resulted 
in increased levels of cell activation. This possibility was sup-
ported by previous reports showing that macrophages, B cells, 
and epithelial cells infected with microbes resulted in higher 
levels of MAIT cell stimulation (5, 14, 23). We first optimized 
the preparation of H. pylori-infected targets by infecting THP-1 
Mϕ with H. pylori at different MOI (10, 20, 50, and 100) and 
FigUre 1 | MaiT cells are present in the human gastric mucosa and exhibit T effector memory phenotype. (a) Identification of MAIT cell subsets [CD8+, 
CD4+, and CD4−CD8− (DN)] in PBMC and (B) in gastric LPMC in a representative individual as CD161hi TCR Vα7.2 (box). (c) Comparison of gastric (red dots; 
n = 27) and PBMC (black squares; n = 29) MAIT cell subsets. Significant differences between MAIT cell subsets in (i) PBMC [black asterisks (*)] and (ii) gastric LPMC 
[red asterisk (*)]. Blue asterisks (*) denote significant differences in MAIT cell subsets between PBMC and LPMC. Horizontal lines represent medians (red bars: 
gastric MAIT; black bars: PBMC MAIT). (D) Expression of CD45RA and CD62L to evaluate memory [TCM (CD62L+CD45RA−), TEM (CD62L−CD45RA−), and TEMRA 
(CD62L−CD45RA+)] and Tnaive (CD62L+CD45RA+) subpopulations in MAIT subsets from PBMC (n = 29) and (e) LPMC (n = 27). (F) Comparison of TEM MAIT cell 
subsets between PBMC and LPMC. *P < 0.05; **P < 0.005; ***P < 0.0005.
evaluating the infection rates in differentiated (CD68+) vs. 
undifferentiated (CD68−) Mϕ using an anti-H. pylori antibody 
and flow cytometry (Figures S3B,C in Supplementary Material). 
We observed that H. pylori were able to infect THP-1 Mϕ 
and the majority of the infected cells were differentiated Mϕ 
(Figure S3B in Supplementary Material). Of note, although 
at 50 and 100 MOI the rates of infection showed the highest 
percentages of H. pylori+ cells, the viability of the Mϕ at these 
MOI decreased to about 70% (Figure S3C in Supplementary 
Material). To further confirm these results, H. pylori-infected 
Mϕ were lysed and plated on agar plates. In agreement with 
flow cytometric assays, a dose-dependence effect was observed 
where the infection level was proportional to the H. pylori MOI 
dose (data not shown). Based on these results, an MOI of 20:1 
was chosen for subsequent experiments in the preparation of H. 
pylori-infected Mϕ.
To investigate whether blood CD8+ MAIT cells could be 
efficiently stimulated by H. pylori-infected Mϕ, MAIT cells 
(effectors) were exposed to either non-infected Mϕ or H. 
pylori-infected Mϕ (targets) with increasing effector:target 
(E:T) ratios (5:1, 10:1, 20:1, and 50:1) and cytokine production 
and CD107a expression measured by flow cytometry. Following 
stimulation with H. pylori-infected THP-1 Mϕ, higher 
FigUre 2 | MaiT cells in blood (PBMc) and gastric lPMc in children, adults, and the elderly. (a) PBMC and (B) gastric LPMC obtained from children 
(n = 12), adults (n = 21), and the elderly (n = 10) were evaluated for the presence of MAIT cells. Significant differences among age groups are denoted by asterisks 
(*P < 0.05). (c) Correlation of CD8+ MAIT cells with age in PBMC (n = 46) and (D) in gastric LPMC (n = 43) was performed using Spearman’s correlation analysis. 
Horizontal green lines in (a,B) represent medians.
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percentages of CD8+ MAIT cells producing cytokines (IFN-γ, 
IL-17A, and TNF-α) and up-regulating expression of CD107a 
were detected than stimulation with non-infected THP-1 Mϕ 
or effectors (Figure  3A). Cumulative data (n  =  11) showed 
that significantly (P < 0.05) higher percentages of blood CD8+ 
MAIT cells produced cytokines (IFN-γ, IL-17A, and TNF-α) 
and expressed elevated levels of CD107a following stimulation 
with H. pylori-infected Mϕ than when exposed to non-infected 
Mϕ (Figures 3B,C).
Blood cD4−cD8− (Dn) MaiT cells activation by 
H. pylori-infected Macrophages
Given that blood CD8+ MAIT cells are reactive to H. pylori and 
that MAIT cells were observed in DN, we next investigated 
whether blood DN MAIT subsets were able to respond to H. 
pylori-infected Mϕ.
We observed that higher percentages of DN MAIT cells 
produced cytokines (IFN-γ, TNF-α, and IL-17A) and up-
regulated CD107a expression following stimulation with H. 
pylori-infected THP-1 Mϕ (E:T – 50:1) than when exposed to 
non-infected Mϕ or when effector cells were cultured alone 
(Figure 4A). Cumulative data (n = 11) showed that significantly 
higher percentages of DN MAIT cells produced cytokines 
(IFN-γ, IL-17, and TNF-α) and up-regulated CD107a following 
stimulation with H. pylori-infected Mϕ than with non-infected 
Mϕ (Figure 4B).
Dominant subsets of Blood MaiT cells 
Following exposure to H. pylori-infected 
Macrophages
Since both blood MAIT subsets (CD8+ and DN) were able to 
recognize and respond to H. pylori-infected THP-1 Mϕ, we then 
examined whether there were differences in the activation levels 
and quality of the responses between these subsets. Following 
stimulation with H. pylori-infected THP-1 Mϕ, increased expres-
sion of the activation marker CD69 was observed in both MAIT 
subsets compared with non-infected Mϕ (Figure 4C). Interestingly, 
both MAIT subsets exhibited similar percentages of CD69+ cells 
(Figure 4C), indicating that CD8+ and DN MAIT subsets are simi-
larly activated by H. pylori-infected macrophages. However, further 
analysis of CD69+ MAIT cells indicated that although CD8+ and 
DN are equally activated (based on similar CD69+ expression lev-
els), significantly higher percentages of CD8+ MAIT cells produced 
cytokines (IFN-γ, TNF-α, and IL-17A) and up-regulated CD107a 
than DN MAIT cells (Figure 4C). Thus, the cytokine responses and 
CD107a expression to H. pylori-infected THP-1 Mϕ are dominated 
by the CD8+ MAIT subset (>60%) (Figure 4C).
Multifunctional MaiT cell responses Following 
exposure to H. pylori-infected Macrophages
Our group has previously shown that MAIT cells can respond 
to S. typhi by secreting multiple cytokines simultaneously (14). 
Thus, we next investigated the multifunctionality of the responses 
FigUre 3 | responses of blood cD8+ MaiT cells from healthy adults to H. pylori-infected macrophages. (a) Representative volunteer showing the 
induction of cytokine production (IFN-γ, TNF-α, IL-17A) and up-regulation of CD107a expression by CD8+ MAIT cells following stimulation by H. pylori-infected 
differentiated THP-1 macrophages (Mϕ) at increasing effector to target (E:T) ratios (5:1, 10:1, 20:1, 50:1). (B) Cumulative data (n = 11) displaying the percentages of 
cytokine-producing and CD107a-expressing CD8+ MAIT cells following stimulation with H. pylori-infected Mϕ (E:T 5:1, 10:1, 20:1, 50:1), non-infected Mϕ, and 
effector cells alone. Shown are significant differences (*) between non-infected and infected targets. Significances were P < 0.0005 for CD107 and TNF-α 
and P < 0.005 for IFN-γ at all E:T ratios and P < 0.05 for IL-17A at 10:1, 20:1, and 50:1 E:T ratios. (c) Cumulative data (n = 11) showing cytokine production and 
expression of CD107a following stimulation with H. pylori-infected Mϕ at E:T (50:1) ratio, non-infected Mϕ, and effector cells alone. Horizontal black lines in (c) 
represent medians. Significant differences were determined between non-infected and H. pylori-infected Mϕ (*P < 0.05; **P < 0.005; ***P < 0.0005).
September 2015 | Volume 6 | Article 4667
Booth et al. MAIT cells in H. pylori infection
Frontiers in Immunology | www.frontiersin.org
exhibited by blood CD8+ MAIT cells against H. pylori-infected 
differentiated THP-1 macrophages. Analysis of multiple cytokines 
(IFN-γ, TNF-α, and IL-17A) and/or CD107 expression patterns 
(16 possible combinations) using the Winlist FCOM function 
revealed that MAIT cell responses were characterized by single, 
double, or triple cytokine producers/CD107 expressors, albeit 
at different percentages, following stimulation with H. pylori-
infected THP-1 Mϕ (Figure  5A). Interestingly, CD8+ MAIT 
cells produced IL-17A mostly as single-cytokine-producing cell 
following stimulation with H. pylori-infected Mϕ. In contrast, 
CD8+ MAIT cells response to H. pylori-infected Mϕ produced 
IFN-γ mostly as multifunctional [triple-positive cells (IFN-γ+ 
TNF-α+ CD107a+)] (Figure 5A). We also noted that the cytotoxic 
marker, CD107a, was prominent in both multifunctional and 
single-positive cell subsets, suggesting that MAIT cells are highly 
cytotoxic to H. pylori-infected THP-1 Mϕ.
MaiT cells are cytotoxic to H. pylori-infected 
Macrophages
Because we observed a preponderance of the cytotoxic degranu-
lation marker CD107a (LAMP-1) expressed on stimulated MAIT 
cells, we directly explored the functional cytotoxic ability of 
MAIT cells to kill H. pylori-infected targets using standard chro-
mium (51Cr) release assays. We observed significant increases 
in target cell killing in cultures containing H. pylori-infected 
THP-1 Mϕ when compared to cultures with non-infected 
THP-1 Mϕ (Figure 5B). To assess whether this MAIT cell killing 
involved MR1-restriction, we treated the stimulator cells with 
anti-human MR1 antibodies or matched immunoglobulin or 
isotype controls to block the lysis of H. pylori-infected THP-1 
Mϕ (Figures 5B,C). We observed that blocking of MR-1 using 
either a goat polyclonal (Figure  5B) or a mouse anti-human 
monoclonal (clone 26.5; Figure  5C) antibodies resulted in 
significant decreases in the lysis of H. pylori-infected THP-1 
Mϕ when compared to cultures with H. pylori-infected targets 
(Figures 5B,C). However, the 26.5 mAb to MR1 was more effec-
tive in preventing lysis of H. pylori targets than the polyclonal 
goat MR1 antibody (Figures  5B,C). As expected, addition of 
matched immunoglobulin (IgC) or isotype (IC) controls failed 
to decrease the lysis of H. pylori-infected Mϕ observed in cul-
tures exposed to H. pylori-infected targets (Figures 5B,C). These 
results confirmed that blood MAIT cells exhibit a cytotoxic 
FigUre 4 | responses of blood cD4−cD8− (Dn) MaiT subsets from healthy adults to H. pylori-infected macrophages. (a) Representative volunteer 
showing the induction of cytokine production (IFN-γ, TNF-α, IL-17A) and up-regulation of CD107a expression in DN MAIT cells following stimulation with media 
(alone), non-infected THP-1 macrophages (Mϕ), or H. pylori-infected THP-1 Mϕ (E:T – 50:1). (B) Cumulative data (n = 11) showing production of cytokines (IFN-γ, 
TNF-α, and IL-17A) and expression of CD107a by DN MAIT cells following stimulation with H. pylori-infected THP-1 Mϕ (E:T – 50:1). (c) CD69 up-regulation by 
CD3+CD161+TCR Vα7.2+ cells following H. pylori-infected THP-1 Mϕ stimulation (E:T – 50:1) and assessment of the level of cytokines production (IFN-γ, TNF-α, 
IL-17A) and CD107a expression in CD69+ MAIT cell subsets (CD8+ and CD4−CD8−) following stimulation with H. pylori-infected THP-1 Mϕ (E:T – 50:1) (n = 11). 
Horizontal black lines in (B,c) represent medians. Significant differences are denoted by asterisks (**P < 0.005).
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effector function to H. pylori-infected THP-1 Mϕ cells and that 
this effect is MR-1 restricted.
MaiT cell subsets (cD8+and cD4−cD8− Dn) 
responses to H. pylori-infected Primary 
autologous Macrophages are Mr-1 restricted
Given that MAIT cells detect bacterially derived antigens pre-
sented by the MHC-like molecule MR-1, we next investigated 
whether responses to H. pylori-infected human primary autolo-
gous macrophages by CD8+ and DN MAIT cell subsets were MR-1 
restricted. To address this question, H. pylori-infected primary 
autologous macrophages were incubated with neutralizing anti-
human MR-1 antibodies or matched isotype controls to block 
the cytokine responses (IFN-γ and TNF-α) and/or expression of 
CD107a elicited in MAIT cells subsets. We observed that blocking 
of MR-1 using a mouse anti-human monoclonal antibody (clone 
26.5; Figure 6A) resulted in significantly decreased production 
of cytokines (IFN-γ and TNF-α) and expression of CD107a by 
CD8+ (Figure 6A) and DN MAIT cell subsets (Figure 6B) when 
compared to cultures with H. pylori-infected autologous targets 
only. In contrast, the addition of a matched isotype (IC) control 
failed to significantly decrease the production of cytokines and 
expression of CD107 by CD8+ (Figure 6A) or DN (CD4−CD8−) 
(Figure  6B) MAIT cells recorded in cultures exposed to H. 
pylori-infected autologous targets. Cumulative data (n  =  5) 
showed significant suppression in the production of cytokines 
(IFN-γ and TNF-α) and expression of CD107 by both MAIT cells 
subsets (CD8+ and DN) following blocking with MR-1 antibody 
but not with a matched isotype control (Figures  6C,D). These 
results indicate that both MAIT cell subsets detect and respond 
to H. pylori-infected primary autologous macrophages and that 
this effect is MR-1 restricted.
gastric MaiT cells activation by H. pylori-
infected Macrophages
Next, we investigated whether gastric MAIT cells would recapitu-
late the immune responses observed in blood MAIT cells against 
H. pylori-infected THP-1 Mϕ. To address this question, isolated 
gastric LPMCs were stimulated with H. pylori-infected THP-1 
Mϕ, non-infected THP-1 Mϕ, anti-CD3/CD28 beads (positive 
control), or media (negative control). Following stimulation with 
H. pylori-infected Mϕ, higher percentages of gastric CD8+ MAIT 
cells produced cytokines (IFN-γ and TNF-α) and up-regulated 
CD107a when compared to the levels following exposure to 
non-infected Mϕ or cells alone (cytograms from a representative 
subject are shown in Figure 7A). Cumulative data (n = 8) showed 
that significantly higher percentages of gastric CD8+ MAIT cells 
produced IFN-γ (5.8 ±  1.8%; mean ±  SE; Figure  7B), TNF-α 
FigUre 5 | Blood MaiT cells from healthy adults exhibit multifunctional abilities and are cytotoxic to H. pylori-infected macrophages. 
(a) Multifunctional activities of MAIT cells were determined by simultaneous detection of three intracellular cytokines (IFN-γ, TNF-α, and IL-17A) and expression of 
CD107a by CD8+ MAIT cells following stimulation with H. pylori-infected THP-1 Mϕ (E:T – 50:1). Scatter plot shows single-cytokine-producing and CD107-
expressing cells and the six predominant multi-cytokine-producing/CD107-expressing patterns using PBMCs from healthy adult volunteers. Horizontal red lines 
indicate the median responses. Multifunctionality was analyzed using the FCOM feature of WinList. (B) H. pylori CTL responses by MAIT cells were measured at 
various effector:target ratios (50:1, 25:1, 12.5:1, 6.25:1) in non-infected (NI) and H. pylori-infected (INF) THP-1 Mϕ. Blocking of CTL responses was performed using 
anti-human MR-1 antibody (goat, polyclonal) (10 μg/ml) or goat IgG control (immunoglobulin control; IgC; 10 μg/ml). (c) H. pylori CTL responses by MAIT cells were 
measured at two effector:target ratios (50:1 and 25:1) in NI and INF THP-1 Mϕ. Blocking of CTL responses were performed using the anti-human MR-1 mAb (clone 
26.5) (10 μg/ml) or a matched isotype control (IC, 10 μg/ml). Lines show the mean percentages of cytotoxicity at different E/T ratios from triplicate wells. The data 
are representative of four separate experiments.
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(8.5 ± 2.1%; mean ± SE; Figure 7C), and up-regulated CD107a 
(8.2  ±  1.0%; mean  ±  SE; Figure  7D) following stimulation 
with H. pylori-infected THP-1 Mϕ compared to non-infected 
Mϕ. A trend, albeit not significant, was also observed for IL-17 
production (Figure 7B). We also determined the percentage of 
responders, i.e., volunteers who exhibited significantly increased 
responses (determined by z-tests based on the number of events 
collected) in the presence of gastric MAIT cells stimulated with 
H. pylori-infected THP-1 Mϕ compared to uninfected Mϕ 
(Figure S4 in Supplementary Material). We observed 87.5, 75, 
and 100% responders for IFN-γ, TNF-α, and CD107a expression, 
respectively (Figure S4 in Supplementary Material).
MaiT cells are lower in PBMc of  
H. pylori-infected Volunteers
Because MAIT cells in both blood and gastric mucosa were found 
to be reactive to H. pylori-infected Mϕ, we speculated that there 
might be differences between MAIT cell frequencies between 
H. pylori-infected (Hp+ve) and uninfected (Hp−ve) volunteers. 
To explore this possibility, we assessed the frequency of MAIT 
cells in PBMC and gastric LPMC obtained from Hp+ve and Hp−ve 
volunteers. We observed significant decreases in the frequency 
of CD8+ MAIT cells in blood of Hp+ve compared with Hp−ve vol-
unteers (Figure 8A). Analysis of the DN MAIT subsets revealed 
significant decreases in the frequencies of PBMC DN MAIT cells 
in Hp+ve when compared with Hp−ve volunteers (Figure  8A). 
These results indicated that decreased levels of CD8+ and DN 
MAIT cell subsets are present in blood during H. pylori infection. 
We then determined the frequency of MAIT cells in the gastric 
mucosa for the same Hp+ve and Hp−ve volunteers. Interestingly, 
no statistically significant differences were observed among the 
LPMC MAIT cell subset frequencies in gastric biopsies obtained 
from Hp+ve and Hp−ve groups (Figure  8B). Since our results 
suggest that MAIT cells in the gastric mucosa are relatively 
constant during aging and infection, we hypothesized that these 
gastric MAIT cells might represent populations of tissue-resident 
FigUre 6 | Mr1 restriction of responses by blood MaiT cD8+ and cD4−cD8− Dn subsets from healthy adults to H. pylori-infected primary 
autologous macrophages. Representative volunteer showing the induction of cytokine production (IFN-γ and TNF-α) and up-regulation of CD107a expression in 
(a) CD8+ and (B) DN MAIT cell subsets following stimulation with non-infected primary autologous macrophages (Mϕ); H. pylori-infected primary autologous Mϕ 
(E:T 5:1 ratio); H. pylori-infected primary autologous Mϕ (E:T – 5:1 ratio) + α-MR1 (26.5 monoclonal ab) (10 μg/ml); or H. pylori-infected primary autologous Mϕ 
(E:T – 5:1 ratio) + isotype control (10 μg/ml). Cumulative data (n = 5) showing MR1-restricted production of IFN-γ, TNF-α, and expression of CD107a by (c) CD8+ 
and (D) DN MAIT cells following stimulation with the four treatments described above. The % of responses compared to media control (% of media control) was 
calculated as (cytokine production/CD107 expression in cells stimulated with H. pylori-infected primary autologous macrophages containing either α-MR1 or IC)/
(cytokine production/CD107 expression in cells stimulated with H. pylori-infected primary macrophages) × 100. Horizontal black lines in (B,D) represent medians. 
Significant differences are denoted by asterisks (*P < 0.05; **P < 0.005).
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cells  (TR). To explore this possibility, we assessed the hallmark 
markers of tissue-resident cells, i.e., expression of CD103 and 
CD69, on gastric LPMC and blood MAIT cells. We observed that 
TR cells (i.e., CD103+ CD69+) represented the majority of MAIT 
cells in gastric LPMC, but only a small proportion in PBMC 
(Figures 8C,D).
Discussion
Mucosal-associated invariant T cells are a class of innate T 
cells widely believed to provide immediate effector functions 
in response to infections in human tissues (5, 24). Here, we 
described, for the first time, the presence of MAIT cells in the 
human gastric mucosa of children, adults, and the elderly and 
characterized their reactivity to H. pylori.
Recent reports indicate a broad distribution of MAIT cells in 
the human body. Human MAIT cells comprise 1–10% of total T 
cells in peripheral blood and in lungs (13, 25), 15–39% in liver (26), 
and 3–5% in intestine (5). Here, we reported that the frequency of 
MAIT cells present in the gastric mucosa range between 0.1 and 
12%. Interestingly, we observed significantly higher percentages 
of MAIT cells expressing a classical TEM phenotype in the gastric 
mucosa than in peripheral blood. These results suggest that the 
gastric MAIT cells have the capacity to act as innate effectors for 
pathogens in the stomach microenvironment.
We also assessed the percentages of MAIT in peripheral blood 
and gastric LPMC from children, adults, and the elderly. These 
assessments are particularly important since few studies have 
compared MAIT cell frequencies among various age groups. 
Interestingly, we observed significantly higher percentages of 
MAIT cells in the blood of children when compared with those 
observed in adults and the elderly. Furthermore, we demonstrate 
that the percentages of CD8+ and DN MAIT subsets in peripheral 
blood are inversely correlated with age. These observations extend 
FigUre 7 | responses of human gastric MaiT cells to H. pylori-infected macrophages. (a) Representative volunteer showing the induction of cytokine 
production (IFN-γ, TNF-α) and expression of CD107a by gastric CD8+ MAIT following stimulation by H. pylori-infected and non-infected THP-1 Mϕ. Shown are 
cumulative data (n = 8) of (B) IFN-γ production, (c) TNF-α production, and (D) expression of CD107a by CD8+ MAIT following stimulation by H. pylori-infected Mϕ 
and non-infected THP-1 Mϕ. Horizontal lines in (B–D) represent medians. Significant differences are denoted by **P < 0.005.
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those reported in very recent studies, which showed that MAIT 
cell frequencies were significantly lower in PBMCs obtained from 
elderly volunteers than in young adult volunteers (27, 28).
These results raise an important question: what is the role 
of MAIT cells in children during infections (e.g., H. pylori)? 
Epidemiological studies have indicated that children infected 
with H. pylori usually develop mild H. pylori-associated gastritis 
but only rarely peptic ulcer or gastric atrophy (29, 30). Based on 
our observations in PBMC, it is reasonable to speculate that the 
higher percentages of MAIT cell in children might be associated 
with protection from severe disease. However, the dichotomy 
observed in the percentages of MAIT cells, which differ among 
age groups when measured in peripheral blood but not in the 
gastric mucosa, suggests that caution has to be exercised when 
interpreting data solely derived from circulating MAIT cells. The 
likelihood that differences exist between MAIT cells in PBMC 
and in the gastric mucosal is supported by our results showing 
that the majority of gastric MAIT cells (>80%) express tissue-
resident markers (CD69+ CD103+), which are absent in PBMC 
MAIT. Additional studies to evaluate in detail the phenotype and 
function of MAIT cells in circulation and in the gastric mucosa 
are needed to conclusively establish the role of these MAIT cells 
in response to H. pylori infection.
The study of host immunological responses to H. pylori is a 
field of intense research (15). Following H. pylori colonization 
of the gastric mucosa, there is a significant influx of immune 
cells into the LP, including macrophages, dendritic cells (DCs), 
B cells, neutrophils, and T cells, which modulate the immuno-
logical microenvironment toward a Th1-type response (31, 32). 
Interestingly, these studies found an abundance of T cells in the 
antrum of H. pylori-infected donors (33). The present study is the 
first to describe the interactions between peripheral blood and 
gastric MAIT cells with H. pylori. We observed that MAIT from 
both tissues reacted to H. pylori by producing Th1 (TNF-α, IFN-γ) 
FigUre 8 | MaiT cells are lower in blood but not in the gastric mucosa of H. pylori-infected volunteers. Aggregate data of the percentages of MAIT cell 
subsets (CD8+ and CD4−CD8−) in H. pylori-negative (Hp−ve) (n = 20) and H. pylori-positive (Hp+ve) (n = 5) volunteers in (a) PBMC and (B) gastric LPMC. Hp−ve 
volunteers were age-matched to Hp+ve volunteers. (c) Representative example of tissue-resident T markers (CD69 and CD103) expression on CD8+ MAIT cells from 
PBMC and gastric LPMC. (D) Cumulative data (n = 6) comparing the expression of TR MAIT cells in PBMC and LPMC. Horizontal lines in (a,B,D) represent 
medians. Significant differences are denoted by asterisks (*P < 0.05, **P < 0.005).
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and TH17 (IL-17A) cytokines as well as acquiring cytotoxic effec-
tor function (expression of CD107a and lysis of H. pylori-infected 
Mϕ). Classical T cells have been implicated in the modulation of 
the gastric mucosa toward Th1- and Th17-type responses follow-
ing H. pylori infection (32, 34). Here, we show that MAIT cells are 
also able to produce these proinflammatory cytokines following 
H. pylori stimulation. These observations suggest that MAIT cells 
are likely to play an important role in contributing to establish a 
Th1/Th17-type environment in the human gastric mucosa during 
H. pylori infection.
A key question that remains unanswered is whether MAIT cells 
are protective or enhance the pathogenicity of H. pylori infection. 
We hypothesize that MAIT cells may likely play an essential role 
in eliminating the bacteria due to its ability to produce high levels 
of Th1 cytokines (associated with protection) and being cytotoxic. 
Of note, we observed that a small fraction of MAIT cells have 
multifunctional capability against H. pylori-infected cells. These 
cells, which are able to produce simultaneously IFN-γ and TNF-
α and exhibit cytotoxic effector functions, might be particularly 
effective in controlling H. pylori infection. In the present study, 
we show, using two complementary approaches, that MAIT 
cells have cytotoxic capabilities against H. pylori-infected cells. 
Although following H. pylori colonization, the bacteria usually 
reside in the mucus layer outside the gastric mucosa, it has been 
recently shown that the bacteria can infect epithelial cells and 
LPMC becoming a facultative intracellular bacteria (35), and 
a recent report has shown that MAIT cells can lyse bacterially 
infected epithelial cells (23). Thus, lysis of H. pylori-infected 
cells by MAIT cells could serve as a bridge between innate and 
classical T cells by eliminating H. pylori-infected cells soon after 
infection. Future studies directed to address MAIT cell responses 
to H. pylori-infected cells in H. pylori-infected and non-infected 
individuals, both systemically and in the gastric microenviron-
ment, will be required to determine the precise role of MAIT cells 
in H. pylori infection.
It has recently been shown that products of the riboflavin 
metabolic pathway lead to MAIT cell activation. For example, 
5 amino-6-d-ribitylaminouracil (5-A-RU) after non-enzymatic 
condensation with glyoxal or methylglyoxal results in the for-
mation of 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil 
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(5-OP-RU), which is an unstable intermediate captured by 
MR-1 resulting in MAIT cell activation (36). However, it has 
been suggested that different bacteria might activate MAIT cells 
through other ligands (37). Moreover, various factors such as 
virulence factors, location of pathogen (e.g., intracellular), and 
type of APCs may also influence the response of MAIT cells to 
defined pathogens (38). However, since H. pylori express genes 
of the riboflavin metabolic pathway, it is likely that MAIT cells 
activation by H. pylori results, at least in part, from products of 
the riboflavin operon.
Another interesting observation in the present study is that 
the percentages of MAIT cells in PBMC of individuals infected 
with H. pylori (Hp+ve) are significantly decreased as compared 
to those from uninfected (Hp−ve) individuals. These results are 
in agreement with those observed in individuals with other 
active infections. For example, Le Bourhis et  al. observed 
significantly lower proportions of MAIT cells in the blood 
of patients with pulmonary bacterial pathologies, including 
tuberculosis (4). Likewise, Gold et  al. demonstrated that M. 
tuberculosis (Mtb)-reactive MAIT were decreased in PBMC but 
enriched in human lungs (13). These observations further sup-
port the existence of a dichotomy between MAIT cells present 
in peripheral blood and those in peripheral tissues. This is an 
important consideration since, largely due to the difficulty in 
obtaining peripheral tissues in humans, the interpretation of 
what might constitute a protective immune response is based 
largely on observations derived from studying peripheral 
blood. Our results showing decreased levels of MAIT cells in 
circulation suggest that these cells may have left peripheral 
blood to infiltrate gastric tissues after H. pylori infection. To 
address this hypothesis, we determined the percentages of 
MAIT cells in circulation and in the gastric mucosa of indi-
vidual H. pylori-positive volunteers. No statistically significant 
differences were observed in the percentages of MAIT cells 
in the gastric mucosa of healthy and H. pylori-infected vol-
unteers. Furthermore, we showed that the majority of gastric 
MAIT cells (>80%) express markers (CD69+ CD103+) compat-
ible with tissue-resident cells, suggesting that MAIT cells can 
acquire a tissue-resident-like phenotype at the gastric mucosa 
and therefore likely to be ready to respond quickly following 
exposure to enteric pathogens.
Regarding the existence of multiple MAIT subsets, Gold and 
Lewinsohn observed that only CD8+ but not DN MAIT cell 
subsets were reactive to M. tuberculosis (1). Moreover, Dusseaux 
et al. noted that there is no evidence (phenotypic or functional) 
suggesting that DN or CD8 subsets are functionally distinct (12). 
However, to our knowledge, there are no other reports describing 
DN MAIT cell reactivity to pathogens. Here, we provide evidence 
that DN MAIT subsets are reactive to H. pylori and show that 
these responses are MR-1 restricted. In addition, our results dem-
onstrate differences among the MAIT subsets in terms of their 
basal levels of activation and percentages, but not in the quality 
of responses, depending on whether they are in circulation or in 
the gastric mucosa.
In conclusion, we have demonstrated the presence of MAIT 
cells in the human stomach and its likely role in the host immune 
response to H. pylori infection as well as provided evidence for the 
role of CD8+ and DN MAIT cell subsets in infection.
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